Analyst says Annual sales could hit $10 M // CPRX must pay royalties to BMRN & many others
This brutally pumped scam will never make a penny because they burn almost $10 M per Quarter . Everyone with a brain should realize that this scam will never survive except if they diluting the hell out of this scam and thats what they already did in the past and still doing .
Firdapse hit the market in Europe in April 2010 and through the first nine months of this year registered sales of $10.8 million.
BioMarin's $5 million investment in Catalyst will convert into Catalyst common stock at some time in the future, Catalyst said in a press release. Catalyst also will owe royalty payments to BioMarin as well as milestones and royalties to former Huxley shareholders and to an undisclosed third-party licensor of the Firdapse rights that are now sublicensed to Catalyst.